Christopher Runnells

Mr. Runnells serves as CEO of Suture Concepts and as a board member of Suture Concepts, Anchor Innovation Medical, and Flexuspine Inc. Mr. Runnells works for the Vertical Group, a medical device venture capital group. Mr. Runnells focuses most of his time in the spine and orthopedic markets.

Prior to Suture Concepts, Mr. Runnells held positions at Tornier Inc., including director of US sales force operations, and International Marketing and Business Development Director for Sports Medicine where he launched the sports medicine business in the US and subsequently internationally out of the Grenoble, France headquarters. Mr. Runnells arrived at Tornier via its acquisition of Axya Medical where he held the position of VP, Business Development. Mr. Runnells went to Axya after serving as a new investment analyst at The Vertical Group.

Mr. Runnells started his career at UBS Investment Bank in New York City where his was an Executive Director in equity research managing the Tech Research team and then implementing the new global rating system and Sarbanes-Oxley compliance measures from London.

Mr. Runnells received an MBA from the Leonard N. Stern School of Business at NYU. He received a BA in History and Political Science from Bucknell University.